Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice.

Blancas I, Fontanillas M, Conde V, Lao J, Martínez E, Sotelo MJ, Jaen A, Bayo JL, Carabantes F, Illarramendi JJ, Gordon MM, Cruz J, García-Palomo A, Mendiola C, Pérez-Ruiz E, Bofill JS, Baena-Cañada JM, Jáñez NM, Esquerdo G, Ruiz-Borrego M.

Clin Transl Oncol. 2018 Jul;20(7):862-869. doi: 10.1007/s12094-017-1797-9. Epub 2017 Nov 24.

PMID:
29178019
2.

Psychosocial determinants of HIV testing across stages of change in Spanish population: a cross-sectional national survey.

Fuster-RuizdeApodaca MJ, Laguia A, Molero F, Toledo J, Arrillaga A, Jaen A.

BMC Public Health. 2017 Mar 7;17(1):234. doi: 10.1186/s12889-017-4148-4.

3.

Which is the Best Screening Strategy for COPD among Smokers in Primary Care?

Llordés M, Zurdo E, Jaén Á, Vázquez I, Pastrana L, Miravitlles M.

COPD. 2017 Feb;14(1):43-51. doi: 10.1080/15412555.2016.1239703. Epub 2016 Oct 31.

PMID:
27797591
4.

Sex differences in N-palmitoylethanolamide effectiveness in neuropathic pain associated with lumbosciatalgia.

Morera C, Sabates S, Jaen A.

Pain Manag. 2015;5(2):81-7. doi: 10.2217/pmt.15.5.

PMID:
25806902
5.

Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007-2012).

Monge S, Díez M, Alvarez M, Guillot V, Iribarren JA, Palacios R, Delgado R, Jaén A, Blanco JR, Domingo P, Portilla J, Pérez Elías MJ, Garcia F; Cohorte de la Red de Investigación en Sida (CoRIS).

Clin Microbiol Infect. 2015 Jan;21(1):105.e1-5. doi: 10.1016/j.cmi.2014.08.007. Epub 2014 Oct 29.

6.

[Usefulness of Quantiferon-TB Gold in Tube® in screening for latent tuberculosis infection in health workers].

Martinez-Lacasa X, Font R, Gonzalez S, Sallent S, Jaen A, Lite J, Cuchi E.

Enferm Infecc Microbiol Clin. 2015 Oct;33(8):525-31. doi: 10.1016/j.eimc.2014.11.006. Epub 2015 Jan 20. Spanish.

PMID:
25613557
7.

Prevalence, Risk Factors and Diagnostic Accuracy of COPD Among Smokers in Primary Care.

Llordés M, Jaén A, Almagro P, Heredia JL, Morera J, Soriano JB, Miravitlles M.

COPD. 2015 Aug;12(4):404-12. doi: 10.3109/15412555.2014.974736.

PMID:
25474184
8.

HIV-infection, atherosclerosis and the inflammatory pathway: candidate gene study in a Spanish HIV-infected population.

Ibáñez L, Velli PS, Font R, Jaén A, Royo J, Irigoyen D, Cairó M, De la Sierra A, Arranz MJ, Gallardo D, Dalmau D.

PLoS One. 2014 Nov 10;9(11):e112279. doi: 10.1371/journal.pone.0112279. eCollection 2014.

9.

Final results of a phase II study of paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer.

Salvador J, Manso L, de la Haba J, Jaen A, Ciruelos E, de Villena MC, Gil M, Murias A, Galan A, Jara C, Bayo J, Baena JM, Casal J, Mel JR, Blancas I, Sanchez Rvira P.

Clin Transl Oncol. 2015 Feb;17(2):160-6. doi: 10.1007/s12094-014-1210-x. Epub 2014 Aug 14.

PMID:
25119930
10.

Evolution of HIV-related stigma in Spain between 2008 and 2012.

Fuster-RuizdeApodaca MJ, Molero F, Gil de Montes L, Agirrezabal A, Toledo J, Jaen A; Spanish Group for the Study of HIV-Related Stigma.

AIDS Care. 2014;26 Suppl 1:S41-5. doi: 10.1080/09540121.2014.906557. Epub 2014 Apr 10.

PMID:
24720687
11.

Tacalcitol in the treatment of acquired perforating collagenosis.

Escribano-Stablé JC, Doménech C, Matarredona J, Pascual JC, Jaen A, Vicente J.

Case Rep Dermatol. 2014 Feb 27;6(1):69-73. doi: 10.1159/000360390. eCollection 2014 Jan.

12.

Catecholamine-induced myocarditis in pheochromocytoma.

de Miguel V, Arias A, Paissan A, de Arenaza DP, Pietrani M, Jurado A, Jaén A, Fainstein Day P.

Circulation. 2014 Mar 25;129(12):1348-9. doi: 10.1161/CIRCULATIONAHA.113.002762. No abstract available.

13.

HIV-associated neurocognitive disorders.

Sanmarti M, Ibáñez L, Huertas S, Badenes D, Dalmau D, Slevin M, Krupinski J, Popa-Wagner A, Jaen A.

J Mol Psychiatry. 2014 Mar 4;2(1):2. doi: 10.1186/2049-9256-2-2. eCollection 2014. Review.

14.

Proliferation determined by ki67 marker and pCR in locally advanced breast cancer patients treated with neo-adjuvant chemotherapy.

Sánchez-Muñoz A, Plata-Fernández Y, Jaén A, Lomas M, Fernández M, Llácer C, Fernández M, Ribelles N, Alba E, Sánchez-Rovira P.

Breast J. 2013 Nov-Dec;19(6):685-6. doi: 10.1111/tbj.12194. Epub 2013 Sep 30. No abstract available.

PMID:
24118566
15.

[Cognitive complaints in people with human immunodeficiency virus in Spain: prevalence and related variables].

Muñoz-Moreno JA, Fuster-Ruiz de Apodaca MJ, Fumaz CR, Ferrer MJ, Molero F, Jaen À, Clotet B, Dalmau D.

Med Clin (Barc). 2014 May 20;142(10):438-44. doi: 10.1016/j.medcli.2013.02.037. Epub 2013 Jun 4. Spanish.

PMID:
23756116
16.

Bevacizumab plus preoperative chemotherapy in operable HER2 negative breast cancer: biomarkers and pathologic response.

Sánchez-Rovira P, Seguí MA, Llombart A, Aranda E, Antón A, Sánchez A, Lomas M, Jaén A, Fernández M, Porras I, Dalmau E, Morales S, de la Haba-Rodríguez J.

Clin Transl Oncol. 2013 Oct;15(10):810-7. doi: 10.1007/s12094-013-1006-4. Epub 2013 Feb 9.

17.

Monitoring HIV viral load in resource limited settings: still a matter of debate?

Arnedo M, Alonso E, Eisenberg N, Ibáñez L, Ferreyra C, Jaén A, Flevaud L, Khamadi S, Roddy P, Gatell JM, Dalmau D; Busia O R Study Group.

PLoS One. 2012;7(12):e47391. doi: 10.1371/journal.pone.0047391. Epub 2012 Dec 6.

18.

Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy.

Betancor G, Garriga C, Puertas MC, Nevot M, Anta L, Blanco JL, Pérez-Elías MJ, de Mendoza C, Martínez MA, Martinez-Picado J, Menéndez-Arias L; Resistance Platform of the Spanish AIDS Research Network (ResRIS), Iribarren JA, Caballero E, Ribera E, Llibre JM, Clotet B, Jaén A, Dalmau D, Gatel JM, Peraire J, Vidal F, Vidal C, Riera M, Córdoba J, López Aldeguer J, Galindo MJ, Gutiérrez F, Álvarez M, García F, Pérez-Romero P, Viciana P, Leal M, Palomares JC, Pineda JA, Viciana I, Santos J, Rodríguez P, Gómez Sirvent JL, Gutiérrez C, Moreno S, Pérez-Olmeda M, Alcamí J, Rodríguez C, del Romero J, Cañizares A, Pedreira J, Miralles C, Ocampo A, Morano L, Aguilera A, Garrido C, Manuzza G, Poveda E, Soriano V.

Retrovirology. 2012 Aug 13;9:68. doi: 10.1186/1742-4690-9-68.

19.

Facial hidradenitis suppurativa in a 28-year-old male responding to finasteride.

Doménech C, Matarredona J, Escribano-Stablé JC, Devesa JP, Vicente J, Jaén A.

Dermatology. 2012;224(4):307-8. Epub 2012 Jun 28. No abstract available.

20.

Pegylated liposomal doxorubicin in combination with cyclophosphamide and trastuzumab in HER2-positive metastatic breast cancer patients: efficacy and cardiac safety from the GEICAM/2004-05 study.

Martín M, Sánchez-Rovira P, Muñoz M, Baena-Cañada JM, Mel JR, Margeli M, Ramos M, Martínez E, García-Saenz JA, Casado A, Jaén AM, González-Farré X, Escudero MJ, Rodriguez-Martin C, Carrasco E; GEICAM.

Ann Oncol. 2011 Dec;22(12):2591-6. doi: 10.1093/annonc/mdr024. Epub 2011 Mar 17.

PMID:
21421542
21.

Sensitivity of seven HIV subtyping tools differs among subtypes/recombinants in the Spanish cohort of naïve HIV-infected patients (CoRIS).

Yebra G, de Mulder M, Martín L, Pérez-Cachafeiro S, Rodríguez C, Labarga P, García F, Tural C, Jaén A, Navarro G, Holguín A; Cohort of Spanish AIDS Research Network (CoRIS).

Antiviral Res. 2011 Jan;89(1):19-25. doi: 10.1016/j.antiviral.2010.10.008. Epub 2010 Nov 9.

PMID:
21070813
22.

[Trichophyton violaceum: an emerging pathogen].

Juncosa T, Aguilera P, Jaen A, Vicente A, Aguilar AC, Fumadó V.

Enferm Infecc Microbiol Clin. 2008 Oct;26(8):502-4. Spanish.

PMID:
19094864
23.

HIV-1 infected patients older than 50 years. PISCIS cohort study.

Navarro G, Nogueras MM, Segura F, Casabona J, Miro JM, Murillas J, Tural C, Ferrer E, Jaén A, Force L, Vilaró J, García I, Masabeu A, Altés J, Esteve A, Sued O, Riera M, Clotet B, Podzamczer D, Gatell JM; PISCIS Study Group.

J Infect. 2008 Jul;57(1):64-71. doi: 10.1016/j.jinf.2008.05.003. Epub 2008 Jun 24.

PMID:
18572247
24.

Determinants of HIV progression and assessment of the optimal time to initiate highly active antiretroviral therapy: PISCIS Cohort (Spain).

Jaén A, Esteve A, Miró JM, Tural C, Montoliu A, Ferrer E, Riera M, Segura F, Force L, Sued O, Vilaró J, Garcia I, Masabeu A, Altès J, Coltet B, Podzamczer D, Murillas J, Navarro G, Gatell JM, Casabona J; PISCIS Study Group.

J Acquir Immune Defic Syndr. 2008 Feb 1;47(2):212-20.

PMID:
18297762
25.

Biweekly docetaxel and gemcitabine as neoadjuvant chemotherapy followed by adjuvant doxorubicin and cyclophosphamide therapy in stage II and III breast cancer patients: results of a phase II study.

Estévez LG, Sánchez-Rovira P, Dómine M, León A, Calvo I, Jaén A, Casado V, Rubio G, Díaz M, Miró C, Lobo F, Carrasco E, Casillas M, San Antonio B.

Clin Transl Oncol. 2007 May;9(5):317-22.

PMID:
17525042
26.
27.

[Clinical-epidemiological characteristics and antiretroviral treatment trends in a cohort of HIV infected patients. The PISCIS Project].

Jaén A, Casabona J, Esteve A, Miró JM, Tural C, Ferrer E, Riera M, Segura F, Force L, Sued O, Vilaró J, Masabeu A, García I, Dorca E, Altès J, Navarro G, Podzamczer D, Villalonga C, Clotet B, Gatell JM; Grupo de Estudio PISCIS.

Med Clin (Barc). 2005 Apr 16;124(14):525-31. Spanish.

PMID:
15847748
28.

Relations between respiratory symptoms and spirometric values in young adults: the European community respiratory health study.

Sunyer J, Basagaña X, Roca J, Urrutia I, Jaen A, Antó JM, Burney P; ECRHS study.

Respir Med. 2004 Oct;98(10):1025-33.

29.

Evaluation of specific occupational asthma risks in a community-based study with special reference to single and multiple exposures.

Zock JP, Cavallé N, Kromhout H, Kennedy SM, Sunyer J, Jaén A, Muniozguren N, Payo F, Almar E, Sánchez JL, Antó JM, Kogevinas M.

J Expo Anal Environ Epidemiol. 2004 Sep;14(5):397-403.

30.

Biweekly docetaxel and gemcitabine as neoadjuvant chemotherapy in stage II and III breast cancer patients: preliminary results of a phase II and pharmacogenomic study.

Estévez LG, Sánchez-Rovira P, Dómine M, León A, Calvo I, Jaén A, Casado V, Rubio G, Daz M, Miró C, Lobo F.

Semin Oncol. 2004 Apr;31(2 Suppl 5):31-6.

PMID:
15199530
31.

Specific sensitization to common allergens and pulmonary function in the European Community Respiratory Health Survey.

Jaén A, Sunyer J, Basagaña X, Chinn S, Zock JP, Antó JM, Burney P; European Community Respiratory Health Survey.

Clin Exp Allergy. 2002 Dec;32(12):1713-9.

PMID:
12653161
32.

Neoadjuvant gemcitabine therapy for breast cancer.

Sánchez-Rovira P, Jaén A, Dueñas R, Porras I, Martínez E, Medina B, Mohedano N, Fernández M, Lozano A.

Clin Breast Cancer. 2002 May;3 Suppl 1:39-44. Review.

PMID:
12057045
33.
34.

Phase II trial of gemcitabine/doxorubicin/paclitaxel administered every other week in patients with metastatic breast cancer.

Sánchez-Rovira P, Jaén A, González E, Porras I, Dueñas MR, Medina B, Mohedano N, Fernández M, Martos M, Lozano A.

Clin Breast Cancer. 2000 Oct;1(3):226-32.

PMID:
11899647
35.

[Paraneoplastic sensory neuropathy due to pharynx and tonsil squamous cell carcinoma].

Pericot I, Río J, Jaén A, Crespo F, Codina A.

Neurologia. 2001 May;16(5):237-9. Spanish. No abstract available.

PMID:
11412728
36.

Biweekly gemcitabine, doxorubicin, and paclitaxel as first-line treatment in metastatic breast cancer. Final results from a phase II trial.

Sánchez-Rovira P, Jaén A, González E, Porras I, Dueñas R, Medina B, Mohedano N, Fernández M, Martos M, Lozano A, Carrasco E.

Oncology (Williston Park). 2001 Feb;15(2 Suppl 3):44-7.

37.

[Prevalence of chronic bronchitis, asthma and airflow limitation in an urban-industrial area of Catalonia].

Jaén A, Ferrer A, Ormaza I, Rué M, Domingo C, Marín A.

Arch Bronconeumol. 1999 Mar;35(3):122-8. Spanish.

PMID:
10216744
38.

Diagnosis of visceral leishmaniasis in HIV-infected patients.

Gasser I, Jaén A, González J, Ribera E.

Eur J Clin Microbiol Infect Dis. 1996 Dec;15(12):967-8. No abstract available.

PMID:
9031887
39.

Lipoid proteinosis of the small bowel.

Caccamo D, Jaen A, Telenta M, Varela E, Tiscornia O.

Arch Pathol Lab Med. 1994 May;118(5):572-4.

PMID:
7514865
40.

[A "ground-glass" computerized tomography image in an HIV-positive patient with a febrile syndrome].

Dolors Torremorell M, Mas A, Domingo C, Mata JM, Jaén A.

Enferm Infecc Microbiol Clin. 1994 Apr;12(4):213-4. Spanish. No abstract available.

PMID:
8031889
41.

[Bronchiolitis obliterans with organized pneumonia secondary to gold salts].

Abeledo C, Jolis R, Jaén A, Hernández L.

Med Clin (Barc). 1993 Oct 30;101(14):558-9. Spanish. No abstract available.

PMID:
8231406
42.

[Thyroid sarcoidosis associated with papillary carcinoma].

Cecchin GV, Jaen A, González Cueto D, Chiesa D.

Medicina (B Aires). 1991;51(3):282. Spanish. No abstract available.

PMID:
1821914
43.

Abnormal chromatin clumping in leucocytes: a clue to a new subtype of myelodysplastic syndrome.

Jaén A, Irriguible D, Milla F, Vallespi T, Torrabadella M, Abella E, Lafuente R, Woessner S.

Eur J Haematol. 1990 Oct;45(4):209-14.

PMID:
2226739
44.

[Burkitt's lymphoma in a patient, a parenteral drug addict, with acquired immunodeficiency syndrome].

Sanz E, Butí M, de Luis A, Jaén A, Ruiz-Marcellán C, Esteban R, Guardia J.

Med Clin (Barc). 1988 Apr 30;90(17):702-3. Spanish. No abstract available.

PMID:
3166088
45.

[Diabetes and pregnancy. Cases studied at Santo Tomás Hospital from 1980 to 1985].

Jaén AL, Brown M.

Rev Med Panama. 1986 Jan;11(1):31-8. Spanish. No abstract available.

PMID:
3726186
46.

Myelodysplastic syndromes: a study of 101 cases according to the FAB classification.

Vallespi T, Torrabadella M, Julia A, Irriguible D, Jaen A, Acebedo G, Triginer J.

Br J Haematol. 1985 Sep;61(1):83-92.

PMID:
3863667

Supplemental Content

Support Center